NCT07364955 Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma
| NCT ID | NCT07364955 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Albert Torrents Torrero |
| Condition | Vestibular Schwannoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-09-01 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Brief Summary The purpose of this clinical trial is to evaluate whether different strategies of vestibular rehabilitation, performed before and after surgery, can improve recovery in adults diagnosed with unilateral vestibular schwannoma. The main questions the study aims to answer are: Does preoperative vestibular telerehabilitation improve postoperative vestibular compensation compared with no intervention? Does adding preoperative rotatory chair stimulation to telerehabilitation lead to greater improvements in balance, dizziness, or hospital length of stay? The study includes three comparison groups: No-intervention group: Participants do not receive pre- or postoperative rehabilitation, but complete all study assessments (vHIT, DHI, posturography, and hospital length of stay). Telerehabilitation group: Participants complete a structured home-based vestibular telerehabilitation program (ReHub) for 3 weeks before surgery and again for 3 weeks after surgery. Rotatory Chair + Telerehabilitation group: Participants receive the same telerehabilitation program as the telerehabilitation group, plus six supervised sessions of preoperative rotatory chair stimulation (two sessions per week for three weeks), following a progressive protocol in the ENT department using a CE-marked clinical rotatory chair. Participants will: Attend routine preoperative and postoperative assessments (vHIT, posturography, and DHI). Complete home-based vestibular exercises through a digital telerehabilitation platform (Groups 2 and 3). If assigned to the Rotatory Chair + Telerehabilitation group, attend six in-hospital sessions of controlled rotatory chair stimulation during the three weeks before surgery. Undergo follow-up evaluations at 4 and 12 weeks after surgery. This study aims to determine whether structured vestibular training conducted before and after surgery can enhance postoperative compensation and reduce symptom burden in patients undergoing vestibular schwannoma surgery.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 70 years * Tumor size between 1.5 cm and 4 cm * Unilateral vestibular schwannoma Exclusion Criteria: * Degenerative neurological conditions * History of cerebrovascular disease * Musculoskeletal deformities
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07364955 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Vestibular Schwannoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07364955 currently recruiting?
Yes, NCT07364955 is actively recruiting participants. Contact the research team at albert.torrents1@gmail.com for enrollment information.
Where is the NCT07364955 trial being conducted?
This trial is being conducted at Badalona, Spain.
Who is sponsoring the NCT07364955 clinical trial?
NCT07364955 is sponsored by Albert Torrents Torrero. The trial plans to enroll 75 participants.